Director/PDMR Shareholding
Source: RNS9 June 2020
Induction Healthcare Group PLC
("Induction", the "Company" or the "Group")
Director/PDMR Shareholdings
Further to the Company's announcement on 5 June 2020 (RNS number 1155P), the Company hereby provides the following notification, made in accordance with the requirements of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
James Balmain |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status |
Joint Group CEO |
|
|
b) |
Initial notification /Amendment |
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Induction Healthcare Group PLC |
|
|
b) |
Legal Entity Identifier |
213800RY96GCZQW5TP19 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 0.5 pence each of the Company
GB00BJ0M3545 |
|
|
b) |
Nature of the transaction |
Consideration shares issued as a result of Induction's acquisition of Zesty Limited. |
|
|
c) |
Currency |
GBP |
|
|
d) |
Price(s) and volume(s) |
Price |
Volume |
|
N/A |
699,391 |
||
|
e) |
Aggregated information - Aggregated volume - Price - Aggregated total |
N/A |
|
|
f) |
Date of the transaction |
9 June 2020 |
|
|
g) |
Place of the transaction |
Outside of trading venue |
|
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Andrew Williams |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status |
Non-Executive Director |
|
|
b) |
Initial notification /Amendment |
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Induction Healthcare Group PLC |
|
|
b) |
Legal Entity Identifier |
213800RY96GCZQW5TP19 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 0.5 pence each of the Company
GB00BJ0M3545 |
|
|
b) |
Nature of the transaction |
Consideration shares issued as a result of Induction's acquisition of Zesty Limited. |
|
|
c) |
Currency |
GBP |
|
|
d) |
Price(s) and volume(s) |
Price |
Volume |
|
N/A |
419,495 |
||
|
e) |
Aggregated information - Aggregated volume - Price - Aggregated total |
N/A |
|
|
f) |
Date of the transaction |
9 June 2020 |
|
|
g) |
Place of the transaction |
Outside of trading venue |
|
-Ends-
ENQUIRIES
|
Induction Healthcare Group PLC Shelley Fraser, Chief Financial Officer
|
via FTI Consulting |
|
Numis Securities (Nominated Adviser and Broker) James Black / Freddie Barnfield / Huw Jeremy / Matthew Jones
|
+44 (0) 207 260 1000 |
|
FTI Consulting Jamie Ricketts / Elena Kalinskaya / Sam Purewal / Mary Whittow |
+44 (0) 203 727 1000 |
About Induction
Induction Healthcare Group PLC is a leading healthcare technology company that helps healthcare professionals deliver better care more efficiently. The Group has two platforms, Induction and MicroGuide, that support healthcare professionals in multiple markets, including UK, Ireland, Australia and South Africa. Induction is the number one healthcare collaboration app in the UK. The app helps over 140,000 users - mostly doctors - to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting. The MicroGuide platform provides medical organisations with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. The Induction app is used by the majority of hospital doctors within the NHS. The MicroGuide platform is used by the majority of trusts within the NHS.
As at 1 May 2020, the Induction app had 140,819 registered users, primarily in the UK. The registered user base grew by 67.2% from 1 May 2019 to 1 May 2020.
As at 1 May 2020, the MicroGuide app had 173,196 registered users, primarily in the UK. The registered user base grew by 36.2% from 1 May 2019 to 1 May 2020.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
